Literature DB >> 12592494

A case of Salla disease with involvement of the cerebellar white matter.

T Linnankivi1, T Lönnqvist, T Autti.   

Abstract

Salla disease (SD) is a lysosomal disorder manifesting in infancy with hypotonia, nystagmus, ataxia and retarded motor development. MRI typically shows hypomyelination confined to the cerebral white matter. We describe a patient with two MRI studies in addition to repeated urine examinations. This case was problematic because the first urine examination did not show the elevation of free sialic acid typical of SD and MRI was also atypical, with abnormal signal intensity in cerebellar white matter. We recommend repeated urinary examinations and a search for SLC17A5 mutations in patients with cerebral signal intensity abnormalities typical of SD and emphasise that cerebellar white-matter involvement on MRI does not exclude the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592494     DOI: 10.1007/s00234-002-0900-1

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  7 in total

1.  A new metabolite contributing to N-acetyl signal in 1H MRS of the brain in Salla disease.

Authors:  T Varho; M Komu; P Sonninen; I Holopainen; S Nyman; T Manner; M Sillanpää; P Aula; N Lundbom
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

2.  Salla disease--rare or underdiagnosed?

Authors:  R O Robinson; A H Fensom; B D Lake
Journal:  Dev Med Child Neurol       Date:  1997-03       Impact factor: 5.449

3.  Brain involvement in Salla disease.

Authors:  P Sonninen; T Autti; T Varho; M Hämäläinen; R Raininko
Journal:  AJNR Am J Neuroradiol       Date:  1999-03       Impact factor: 3.825

4.  A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases.

Authors:  F W Verheijen; E Verbeek; N Aula; C E Beerens; A C Havelaar; M Joosse; L Peltonen; P Aula; H Galjaard; P J van der Spek; G M Mancini
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

5.  Salla disease: a new lysosomal storage disorder with disturbed sialic acid metabolism.

Authors:  M Renlund; P Aula; K O Raivio; S Autio; K Sainio; J Rapola; S L Koskela
Journal:  Neurology       Date:  1983-01       Impact factor: 9.910

6.  The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation.

Authors:  N Aula; P Salomäki; R Timonen; F Verheijen; G Mancini; J E Månsson; P Aula; L Peltonen
Journal:  Am J Hum Genet       Date:  2000-08-17       Impact factor: 11.025

7.  Phenotypic variation and magnetic resonance imaging (MRI) in Salla disease, a free sialic acid storage disorder.

Authors:  L Haataja; R Parkkola; P Sonninen; S L Vanhanen; J Schleutker; T Aärimaa; U Turpeinen; M Renlund; P Aula
Journal:  Neuropediatrics       Date:  1994-10       Impact factor: 1.947

  7 in total
  4 in total

1.  Cerebellar white matter involvement in Salla disease.

Authors:  Roberta Biancheri; A Rossi; M G Mancini; C Minetti
Journal:  Neuroradiology       Date:  2004-06-04       Impact factor: 2.804

Review 2.  Lysosomal Leukodystrophies Lysosomal Storage Diseases Associated With White Matter Abnormalities.

Authors:  Gustavo H B Maegawa
Journal:  J Child Neurol       Date:  2019-02-13       Impact factor: 1.987

Review 3.  Decreased T2 signal in the thalami may be a sign of lysosomal storage disease.

Authors:  Taina Autti; Raimo Joensuu; Laura Aberg
Journal:  Neuroradiology       Date:  2007-03-03       Impact factor: 2.804

4.  Homozygosity for the p.K136E mutation in the SLC17A5 gene as cause of an Italian severe Salla disease.

Authors:  R Biancheri; A Rossi; H A Verbeek; R Schot; F Corsolini; S Assereto; G M S Mancini; F W Verheijen; C Minetti; M Filocamo
Journal:  Neurogenetics       Date:  2005-09-17       Impact factor: 2.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.